Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Vitamin A supplementation of 6-59 month old children is currently recommended by the World Health Organization based on evidence that it reduces mortality. There has been considerable interest in determining the benefits of neonatal...

Full description

Bibliographic Details
Main Authors: Bahl Rajiv, Bhandari Nita, Dube Brinda, Edmond Karen, Fawzi Wafaie, Fontaine Olivier, Kaur Jasmine, Kirkwood Betty R, Martines Jose, Masanja Honorati, Mazumder Sarmila, Msham Salum, Newton Sam, Oleary Maureen, Ruben Julia, Shannon Caitlin, Smith Emily, Taneja Sunita, Yoshida Sachiyo
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Trials
Subjects:
Online Access:http://www.trialsjournal.com/content/13/1/22
_version_ 1818346830571765760
author Bahl Rajiv
Bhandari Nita
Dube Brinda
Edmond Karen
Fawzi Wafaie
Fontaine Olivier
Kaur Jasmine
Kirkwood Betty R
Martines Jose
Masanja Honorati
Mazumder Sarmila
Msham Salum
Newton Sam
Oleary Maureen
Ruben Julia
Shannon Caitlin
Smith Emily
Taneja Sunita
Yoshida Sachiyo
author_facet Bahl Rajiv
Bhandari Nita
Dube Brinda
Edmond Karen
Fawzi Wafaie
Fontaine Olivier
Kaur Jasmine
Kirkwood Betty R
Martines Jose
Masanja Honorati
Mazumder Sarmila
Msham Salum
Newton Sam
Oleary Maureen
Ruben Julia
Shannon Caitlin
Smith Emily
Taneja Sunita
Yoshida Sachiyo
author_sort Bahl Rajiv
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Vitamin A supplementation of 6-59 month old children is currently recommended by the World Health Organization based on evidence that it reduces mortality. There has been considerable interest in determining the benefits of neonatal vitamin A supplementation, but the results of existing trials are conflicting. A technical consultation convened by WHO pointed to the need for larger scale studies in Asia and Africa to inform global policy on the use of neonatal vitamin A supplementation. Three trials were therefore initiated in Ghana, India and Tanzania to determine if vitamin A supplementation (50,000 IU) given to neonates once orally on the day of birth or within the next two days will reduce mortality in the period from supplementation to 6 months of age compared to placebo.</p> <p>Methods/Design</p> <p>The trials are individually randomized, double masked, and placebo controlled. The required sample size is 40,200 in India and 32,000 each in Ghana and Tanzania. The study participants are neonates who fulfil age eligibility, whose families are likely to stay in the study area for the next 6 months, who are able to feed orally, and whose parent(s) provide informed written consent to participate in the study. Neonates randomized to the intervention group receive 50,000 IU vitamin A and the ones randomized to the control group receive placebo at the time of enrolment. Mortality and morbidity information are collected through periodic home visits by a study worker during infancy. The primary outcome of the study is mortality from supplementation to 6 months of age. The secondary outcome of the study is mortality from supplementation to 12 months of age. The three studies will be analysed independent of each other. Subgroup analysis will be carried out to determine the effect by birth weight, sex, and timing of DTP vaccine, socioeconomic groups and maternal large-dose vitamin A supplementation.</p> <p>Discussion</p> <p>The three ongoing studies are the largest studies evaluating the efficacy of vitamin A supplementation to neonates. Policy formulation will be based on the results of efficacy of the intervention from the ongoing randomized controlled trials combined with results of previous studies.</p> <p>Trial Registration</p> <p><b>Ghana: </b>Australian New Zealand Clinical Trials Registry (ANZCTR) - <a href="http://www.anzctr.org.au/ACTRN12610000582055.aspx">ACTRN12610000582055</a><b>; India: </b>CLINICALTRIALS.GOV - <a href="http://www.clinicaltrials.gov/ct2/show/NCT01138449">NCT01138449</a><b>; Tanzania: </b>Australian New Zealand Clinical Trials Registry (ANZCTR) - <a href="http://www.anzctr.org.au/ACTRN12610000636055.aspx">ACTRN12610000636055</a>.</p>
first_indexed 2024-12-13T17:24:30Z
format Article
id doaj.art-3e8c091dd8e94cffa167c37f408b6e4f
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-13T17:24:30Z
publishDate 2012-02-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-3e8c091dd8e94cffa167c37f408b6e4f2022-12-21T23:37:13ZengBMCTrials1745-62152012-02-011312210.1186/1745-6215-13-22Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trialBahl RajivBhandari NitaDube BrindaEdmond KarenFawzi WafaieFontaine OlivierKaur JasmineKirkwood Betty RMartines JoseMasanja HonoratiMazumder SarmilaMsham SalumNewton SamOleary MaureenRuben JuliaShannon CaitlinSmith EmilyTaneja SunitaYoshida Sachiyo<p>Abstract</p> <p>Background</p> <p>Vitamin A supplementation of 6-59 month old children is currently recommended by the World Health Organization based on evidence that it reduces mortality. There has been considerable interest in determining the benefits of neonatal vitamin A supplementation, but the results of existing trials are conflicting. A technical consultation convened by WHO pointed to the need for larger scale studies in Asia and Africa to inform global policy on the use of neonatal vitamin A supplementation. Three trials were therefore initiated in Ghana, India and Tanzania to determine if vitamin A supplementation (50,000 IU) given to neonates once orally on the day of birth or within the next two days will reduce mortality in the period from supplementation to 6 months of age compared to placebo.</p> <p>Methods/Design</p> <p>The trials are individually randomized, double masked, and placebo controlled. The required sample size is 40,200 in India and 32,000 each in Ghana and Tanzania. The study participants are neonates who fulfil age eligibility, whose families are likely to stay in the study area for the next 6 months, who are able to feed orally, and whose parent(s) provide informed written consent to participate in the study. Neonates randomized to the intervention group receive 50,000 IU vitamin A and the ones randomized to the control group receive placebo at the time of enrolment. Mortality and morbidity information are collected through periodic home visits by a study worker during infancy. The primary outcome of the study is mortality from supplementation to 6 months of age. The secondary outcome of the study is mortality from supplementation to 12 months of age. The three studies will be analysed independent of each other. Subgroup analysis will be carried out to determine the effect by birth weight, sex, and timing of DTP vaccine, socioeconomic groups and maternal large-dose vitamin A supplementation.</p> <p>Discussion</p> <p>The three ongoing studies are the largest studies evaluating the efficacy of vitamin A supplementation to neonates. Policy formulation will be based on the results of efficacy of the intervention from the ongoing randomized controlled trials combined with results of previous studies.</p> <p>Trial Registration</p> <p><b>Ghana: </b>Australian New Zealand Clinical Trials Registry (ANZCTR) - <a href="http://www.anzctr.org.au/ACTRN12610000582055.aspx">ACTRN12610000582055</a><b>; India: </b>CLINICALTRIALS.GOV - <a href="http://www.clinicaltrials.gov/ct2/show/NCT01138449">NCT01138449</a><b>; Tanzania: </b>Australian New Zealand Clinical Trials Registry (ANZCTR) - <a href="http://www.anzctr.org.au/ACTRN12610000636055.aspx">ACTRN12610000636055</a>.</p>http://www.trialsjournal.com/content/13/1/22Vitamin Aneonatalinfant mortalityrandomized controlled trial
spellingShingle Bahl Rajiv
Bhandari Nita
Dube Brinda
Edmond Karen
Fawzi Wafaie
Fontaine Olivier
Kaur Jasmine
Kirkwood Betty R
Martines Jose
Masanja Honorati
Mazumder Sarmila
Msham Salum
Newton Sam
Oleary Maureen
Ruben Julia
Shannon Caitlin
Smith Emily
Taneja Sunita
Yoshida Sachiyo
Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial
Trials
Vitamin A
neonatal
infant mortality
randomized controlled trial
title Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial
title_full Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial
title_fullStr Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial
title_full_unstemmed Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial
title_short Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial
title_sort efficacy of early neonatal vitamin a supplementation in reducing mortality during infancy in ghana india and tanzania study protocol for a randomized controlled trial
topic Vitamin A
neonatal
infant mortality
randomized controlled trial
url http://www.trialsjournal.com/content/13/1/22
work_keys_str_mv AT bahlrajiv efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT bhandarinita efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT dubebrinda efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT edmondkaren efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT fawziwafaie efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT fontaineolivier efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT kaurjasmine efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT kirkwoodbettyr efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT martinesjose efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT masanjahonorati efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT mazumdersarmila efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT mshamsalum efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT newtonsam efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT olearymaureen efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT rubenjulia efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT shannoncaitlin efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT smithemily efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT tanejasunita efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial
AT yoshidasachiyo efficacyofearlyneonatalvitaminasupplementationinreducingmortalityduringinfancyinghanaindiaandtanzaniastudyprotocolforarandomizedcontrolledtrial